FIT FIRST FOR ALL - The Dose-Response Study
1 other identifier
interventional
2,400
1 country
1
Brief Summary
In the present study, FIT FIRST 10 will run over 20 weeks, with cardiometabolic fitness as the primary outcome and project acceptability as the co-primary outcome. In this study the investigators will be testing the dose-response of the FIT FIRST concept by having two experimental groups. This will be a cluster RCT with a 1:1:1 recruitment of control schools, intervention schools with 3 weekly 40-min FIT FIRST 10 lessons, and intervention schools with 1.5 weekly 40-min session. There will be recruited a total of 1000 children, with 500 8-9-year-olds from 2nd and 3rd grade in each group from a minimum of 40 classes from 16 schools. There will be subgroup analyses of children with low socioeconomic status and ethnic minority background. Intervention effects will be tested as on health profile, cardiometabolic and musculoskeletal fitness, motivation for physical activity, acceptability of the programme for stakeholders as well as the implementation potential. The study will be running in Q1 and Q2 in 2023. It is hypothesized that the FIT FIRST 10 concept will improve the well-being, increase sports club participation as well as increase fitness and health levels among 8-9-year-old children with low fitness, low socioeconomic and/or ethnic minority background. However, it is also hypothesized that the effects on well-being and fitness levels caused by the intervention may be most significant among ethnic minority children not enrolled in sports clubs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2022
CompletedFirst Submitted
Initial submission to the registry
December 12, 2022
CompletedFirst Posted
Study publicly available on registry
December 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 24, 2024
CompletedDecember 22, 2023
December 1, 2023
2 years
December 12, 2022
December 12, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Cardiometabolic fitness as assessed by the achieved distance in the Yo-Yo IR1 Children's test
Cardiometabolic fitness profile will be evaluated by using the Yo-Yo IR1 Children's test measured as the total distance in meters as an indicator for the participants' ability to perform intermittent exercise and their cardiometabolic fitness. The longer the distance, the better the cardiometabolic fitness of the participants.
Change from baseline to week 20
Project acceptability as assessed by observations and teachers questionnaires
Observations will describe the acceptability and specific teacher questionnaires will be applied to evaluate the acceptability of the project.
Change from baseline to week 20
Secondary Outcomes (9)
Muscle strength of the lower body as assessed by the standing long jump performance
Change from baseline to week 20
Well-being as assessed by the questionnaires KIDSCREEN 27
Change from baseline to week 20
Fat percentage based on bioimpedance.
Change from baseline to week 20
Postural balance as assessed by the stork balance stand test
Change from baseline to week 20
Agility as assessed by the arrowhead agility-test
Change from baseline to week 20
- +4 more secondary outcomes
Study Arms (3)
Control
NO INTERVENTIONContinue normal activities
3/wk
EXPERIMENTALUse FIT FIRST 3 times pr. week
1.5/wk
EXPERIMENTALUse FIT FIRST 1.5 times pr. week
Interventions
Eligibility Criteria
You may qualify if:
- part of enrolled classes
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Denmarklead
- Novo Nordisk A/Scollaborator
- National Olympic Committee and Sports Confederation of Denmarkcollaborator
Study Sites (1)
University of Southern Denmark
Odense, 5000, Denmark
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Krustrup
Syddansk Universitet - Sport og Sundhed (IOB)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 12, 2022
First Posted
December 22, 2023
Study Start
December 10, 2022
Primary Completion
December 24, 2024
Study Completion
December 24, 2024
Last Updated
December 22, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share